$OTLC·4

MATEON THERAPEUTICS INC · Oct 27, 4:28 PM ET

MATEON THERAPEUTICS INC 4

4 · MATEON THERAPEUTICS INC · Filed Oct 27, 2016

Insider Transaction Report

Form 4
Period: 2016-10-25
Transactions
  • Award

    Stock Option (Right to Buy)

    2016-10-25+135,612135,612 total
    Exercise: $0.58Exp: 2022-10-25Common Stock (135,612 underlying)
Footnotes (2)
  • [F1]Dr. Sandage was awarded options to purchase shares of Mateon Therapeutics, Inc. common stock, $0.01 par value per share (the "Stock Options"), in connection with his appointment to the Board of Directors pursuant to the Mateon Therapeutics, Inc. 2015 Equity Incentive Plan and the Amended and Restated Director Compensation Policy.
  • [F2]The Stock Options will vest in three equal annual installments on the first, second and third anniversary of the date of grant, subject to Dr. Sandage's continued service on the Board of Directors as of such date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION